| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Laboratory of Chemical Pharmacology, National Heart Institute, National Institutes of Health, Bethesda, Md.)
6-Chloropurine and 6-chlorouric acid effect specific inhibitions of xanthine oxidase and uricase, respectively, in both slices and homogenates of rat liver. In the rat in vivo, a similarly potent inhibition of uricase is achieved by 6-chlorouric acid, whether administered as such or formed in vivo by the oxidation of 6-chloropurine.
6-Chloropurine in vivo and in liver slices effects only a slight inhibition of nucleic acid biosynthesis as measured by the incorporation of glycine-2-C14 and of P32. The utilization of acetate for lipide synthesis and the incorporation of glycine in protein are similarly decreased to only a small extent in the presence of therapeutic levels of the drug.
Received 4/ 5/61.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |